{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:43:12Z","timestamp":1791240192143,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s35024","type":"journal-article","created":{"date-parts":[[2014,5,25]],"date-time":"2014-05-25T19:27:09Z","timestamp":1401046029000},"page":"225","source":"Crossref","is-referenced-by-count":64,"title":["Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer"],"prefix":"10.2147","author":[{"given":"Felicity","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5]]},"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=20173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:25:00Z","timestamp":1477851900000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/novel-drugs-that-target-the-estrogen-related-receptor-alpha-their-ther-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cmar.s35024","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}